The US FDA advisory committee supports the use of Moderna's influenza vaccine for adults aged 50 and above.

Gelonghui June 22｜The advisory committee of the US Food and Drug Administration (FDA) supports the approval of Moderna's influenza vaccine for adults aged 50 and above, stating that the benefits of the vaccine outweigh the risks. All nine expert panel members voted unanimously in favor of the vaccine for adults aged 50 to 64 and those aged 65 and above.